Fink T, Kuck K H, Metzner A
Abteilung für Kardiologie, Asklepios Klinik St. Georg, 20099, Hamburg, Lohmühlenstraße 5, Deutschland.
Herz. 2015 Dec;40(8):1034-42. doi: 10.1007/s00059-015-4380-6.
The new European Society of Cardiology (ESC) guidelines for the management of patients with ventricular arrhythmia and the prevention of sudden cardiac death, recently published at the annual ESC meeting in London, contain an extensive update of the recommendations for the diagnostics, drug therapy, interventional and device therapy of ventricular arrhythmia. The new recommendations for implantable cardioverter defibrillator (ICD) treatment for primary and secondary prophylaxis of sudden cardiac death can be seen as a focused update of the previously published guidelines. Pre-existing recommendations for catheter ablation of ventricular arrhythmias have been partly extensively expanded with respect to the results of recent clinical trials. The guideline committee also adapted their recommendations regarding the hereditary arrhythmia syndromes to the 2013 consensus report of the American Heart Association (AHA), the European Heart Rhythm Association (EHRA) and the Asia Pacific Heart Rhythm Society (APHRS).
欧洲心脏病学会（ESC）近期于伦敦举行的年度会议上发布了关于室性心律失常患者管理及心脏性猝死预防的新指南，其中对室性心律失常的诊断、药物治疗、介入治疗和器械治疗的建议进行了全面更新。针对心脏性猝死一级和二级预防的植入式心律转复除颤器（ICD）治疗的新建议可视为对先前发布指南的重点更新。鉴于近期临床试验结果，既往关于室性心律失常导管消融的建议部分得到了大幅扩充。指南委员会还根据美国心脏协会（AHA）、欧洲心律协会（EHRA）和亚太心律学会（APHRS）2013年的共识报告，调整了关于遗传性心律失常综合征的建议。
